Paragon 28, Inc. (FNA)

10.16 -0.37 (-3.51%) As of 10:36AM EDT. Market open.

Paragon 28, Inc.

14445 Grasslands Drive
Englewood, CO 80112
United States
855 786 2828
https://paragon28.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 574

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Albert DaCosta	Co-Founder, Chairman, President & CEO	1.4M	N/A	1974
Ms. Kristina Wright	Independent Interim CFO & Director	70k	N/A	1977
Mr. Robert S. McCormack J.D.	General Counsel & Secretary	477.53k	N/A	1968
Mr. Matthew Jarboe	Chief Commercial Officer	899.92k	N/A	1984
Mr. Andrew James Hill	Executive Vice President of Research & Development	306.06k	N/A	1984
Mr. Jeff Sears	Vice President of Operations	N/A	N/A	N/A
Mr. Erik E Mickelson	Chief Accounting Officer & Controller	N/A	N/A	1982
Matt Brinckman	Senior Vice President of Strategy & Investor Relations	N/A	N/A	N/A
Ms. Michelle Missal	VP & Chief Compliance Officer	N/A	N/A	N/A
Mr. John Shumaker	Executive Vice President of Sales - U.S.	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Corporate governance

Paragon 28, Inc.’s ISS governance QualityScore as of 1 May 2024 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 5; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.